By IDSE News Staff
Janus kinase (JAK) inhibitors, specifically ruxolitinib, may significantly decay the viral reservoir of people with HIV, offering a novel pathway toward long-term remission or cure, according to a presentation at the 2023 International AIDS Society (IAS) Conference in Brisbane, Australia.
The HIV viral reservoir, essentially a small number of immune cells containing dormant virus integrated into the genomes of individuals who have suppressed viral replication with HIV